BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 12820969)

  • 1. Modulation of NF-kappaB activity by exchange of dimers.
    Saccani S; Pantano S; Natoli G
    Mol Cell; 2003 Jun; 11(6):1563-74. PubMed ID: 12820969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of different NF-kappaB pathway genes in dendritic cells (DCs) or macrophages assessed by gene expression profiling.
    Baltathakis I; Alcantara O; Boldt DH
    J Cell Biochem; 2001 Aug 1-9; 83(2):281-90. PubMed ID: 11573245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of the transcription factor NF-kappaB during human mononuclear phagocyte differentiation to macrophages and dendritic cells.
    Ammon C; Mondal K; Andreesen R; Krause SW
    Biochem Biophys Res Commun; 2000 Feb; 268(1):99-105. PubMed ID: 10652220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Domain Stability Regulated through the Dimer Interface Controls the Formation Kinetics of a Specific NF-κB Dimer.
    Kumar M; Dhaka N; Raza T; Dadhwal P; Atreya HS; Mukherjee SP
    Biochemistry; 2021 Feb; 60(7):513-523. PubMed ID: 33555182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD40 ligation conditions dendritic cell antigen-presenting function through sustained activation of NF-kappaB.
    O'Sullivan BJ; Thomas R
    J Immunol; 2002 Jun; 168(11):5491-8. PubMed ID: 12023343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers.
    Bonizzi G; Bebien M; Otero DC; Johnson-Vroom KE; Cao Y; Vu D; Jegga AG; Aronow BJ; Ghosh G; Rickert RC; Karin M
    EMBO J; 2004 Oct; 23(21):4202-10. PubMed ID: 15470505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A roadmap of constitutive NF-κB activity in Hodgkin lymphoma: Dominant roles of p50 and p52 revealed by genome-wide analyses.
    de Oliveira KA; Kaergel E; Heinig M; Fontaine JF; Patone G; Muro EM; Mathas S; Hummel M; Andrade-Navarro MA; Hübner N; Scheidereit C
    Genome Med; 2016 Mar; 8(1):28. PubMed ID: 26988706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2,3,7,8-Tetrachlorodibenzo-p-dioxin suppresses tumor necrosis factor-alpha and anti-CD40-induced activation of NF-kappaB/Rel in dendritic cells: p50 homodimer activation is not affected.
    Ruby CE; Leid M; Kerkvliet NI
    Mol Pharmacol; 2002 Sep; 62(3):722-8. PubMed ID: 12181450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The p50-p50 NF-kappaB complex as a stimulus-specific repressor of gene activation.
    Tong X; Yin L; Washington R; Rosenberg DW; Giardina C
    Mol Cell Biochem; 2004 Oct; 265(1-2):171-83. PubMed ID: 15543947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transcriptional specificity of NF-κB dimers is coded within the κB DNA response elements.
    Wang VY; Huang W; Asagiri M; Spann N; Hoffmann A; Glass C; Ghosh G
    Cell Rep; 2012 Oct; 2(4):824-39. PubMed ID: 23063365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimer-specific regulatory mechanisms within the NF-κB family of transcription factors.
    Smale ST
    Immunol Rev; 2012 Mar; 246(1):193-204. PubMed ID: 22435556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of p50/p65 heterodimer of transcription factor NF-kappaB bound to DNA.
    Chen FE; Huang DB; Chen YQ; Ghosh G
    Nature; 1998 Jan; 391(6665):410-3. PubMed ID: 9450761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degradation of promoter-bound p65/RelA is essential for the prompt termination of the nuclear factor kappaB response.
    Saccani S; Marazzi I; Beg AA; Natoli G
    J Exp Med; 2004 Jul; 200(1):107-13. PubMed ID: 15226358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple NF-kappaB and IFN regulatory factor family transcription factors regulate CCL19 gene expression in human monocyte-derived dendritic cells.
    Pietilä TE; Veckman V; Lehtonen A; Lin R; Hiscott J; Julkunen I
    J Immunol; 2007 Jan; 178(1):253-61. PubMed ID: 17182562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A biophysical characterisation of factors controlling dimerisation and selectivity in the NF-kappaB and NFAT families.
    de Lumley M; Hart DJ; Cooper MA; Symeonides S; Blackburn JM
    J Mol Biol; 2004 Jun; 339(5):1059-75. PubMed ID: 15178248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential activation of nuclear factor kappa B subunits in a skin dendritic cell line in response to the strong sensitizer 2,4-dinitrofluorobenzene.
    Cruz MT; Duarte CB; Gonçalo M; Figueiredo A; Carvalho AP; Lopes MC
    Arch Dermatol Res; 2002 Dec; 294(9):419-25. PubMed ID: 12522580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription of the RelB gene is regulated by NF-kappaB.
    Bren GD; Solan NJ; Miyoshi H; Pennington KN; Pobst LJ; Paya CV
    Oncogene; 2001 Nov; 20(53):7722-33. PubMed ID: 11753650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RelB/p50 regulates CCL19 production, but fails to promote human DC maturation.
    Gasparini C; Foxwell BM; Feldmann M
    Eur J Immunol; 2009 Aug; 39(8):2215-23. PubMed ID: 19655301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RelB-p50 NF-kappa B complexes are selectively induced by cytomegalovirus immediate-early protein 1: differential regulation of Bcl-x(L) promoter activity by NF-kappa B family members.
    Jiang HY; Petrovas C; Sonenshein GE
    J Virol; 2002 Jun; 76(11):5737-47. PubMed ID: 11992002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD40 regulates the processing of NF-kappaB2 p100 to p52.
    Coope HJ; Atkinson PG; Huhse B; Belich M; Janzen J; Holman MJ; Klaus GG; Johnston LH; Ley SC
    EMBO J; 2002 Oct; 21(20):5375-85. PubMed ID: 12374738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.